Dr. Pifer was joined by doctors Thomas Julian, William Poller and Mark Trombetta to discuss breast cancer prevention and treatment.
There could be a breakthrough in the fight against breast cancer. A new device may help diagnose a common condition after having breast cancer surgery before it becomes a major problem.
Carie Capossela took the drug Tamoxifen for five years after she was diagnosed with breast cancer at 33. She is now 44.
Once there were four Resnik sisters. Dianna died of breast cancer in 2001 after being diagnosed while pregnant with her second child. The other three sisters are now, in some manner, dealing with it, too.
Are certain breast cancer campaigns making women look like sexual objects? “Save the tatas, save second base…” Do they trivialize the actual woman battling the disease?
Even if you don’t have cancer, would you have your breasts removed?
Saturday will be an emotional day for the Carnegie Mellon football team.
It’s a sight you certainly don’t see every day, thousands of bras lining a walking path on the North Shore. It’s an eye-catching display, but why are they there?
Dr. Pifer was joined in the NewsRadio1020 KDKA Studio for Medical Frontiers by Dr. Kathleen Erb, Dr. Bill Poller and Dr. Larry Wickerham.
A new study shows that breast cancer patients who are obese or even just overweight may be more likely to have the disease come back, even if they have the best treatment.
A new study is raising questions about the medical treatment for older women diagnosed with early-stage breast cancer. Joan Safir, 76, was diagnosed with breast cancer last year.
When you hear things like stroke, Alzheimer’s and gout, you usually think of those as affecting older people. However, there’s a list of diseases out there that are hitting people younger and younger.
In a little over a month, Pittsburgh has its 20th annual Susan G. Komen Race for the Cure. “People are still very angry and I think we’ve lost trust,” admits Pittsburgh affiliate executive director Kathy Purcell.
Avastin for breast cancer is out. The FDA says the drug should no longer be used for breast cancer because there’s no proof it extends patients’ lives – and it causes dangerous side effects.
A woman whose breast cancer came back after she beat it looked to an alternative to fight the recurring cancer instead of a mastectomy.